This study's main goals are to give an overview of chitosan-based nanoparticles used in a variety of non-parenteral applications and to call attention to new research on mucoadhesive and sustained release chitosan dosage forms. Chitosan is a biodegradable, biocompatible polymer that has been certified for use in wound dressings and is suitable for inclusion in human diets. For a variety of drug delivery methods, chitosan has been employed as a drug carrier in polymeric nanoparticles. Chitosan is a polymer with numerous possible uses since it has chemical functional groups that can be altered to serve particular purposes. The positive surface charges and mucoadhesive qualities of nanoparticles (np) made of chitosan and chitosan derivatives enable them to stick to mucous membranes and gradually release the therapeutic payload. This review will include examples of non-parenteral drug delivery techniques for treating eye infections, cancer, gastrointestinal disorders, pulmonary disorders, and cancer. Both in vitro and a few in vivo investigations show that chitosan has a low level of toxicity. This review looks at recent investigations on the characteristics, modifications, toxicity, pharmacokinetics, and preclinical trials of nanoparticles (np) made of chitosan for non-parenteral drug delivery.
Recent fast developments in nanotechnology have stoked a developing interest in the study of nanoparticles, particularly when it comes to medical applications. Understanding the properties of gold nanoparticles (AuNPs) and doing extensive study has resulted to a growing body of information that is pushing the limits of nanotechnology in interesting directions all the time. The use of AuNPs to manage cancer, including its diagnosis, monitoring, and therapy, appears to be of increased attention at the moment. The goal of these initiatives is to fundamentally alter the way that cancer is currently treated. In this article, we will primarily focus on how AuNPs are currently being used to treat cancer.
Throughout the beyond a decade, Food Rule Experts have deduced that caffeine usage isn't risky at whatever point consumed at levels of 200 mg at a time (around 2½ cups of coffee) or 400 mg everyday (around 5 cups of coffee). Moreover, caffeine has various positive exercises on the frontal cortex. It can augment availability and success, help obsession, further foster perspective likewise, limit distress. Caffeine could disturb rest, regardless, simply in fragile individuals. It could raise anxiety in a little subset of particularly fragile people. Caffeine does not seem to provoke dependence, yet a minority of people experience withdrawal secondary effects. Caffeine can potentiate the effect of standard torment alleviating drugs in cerebral agony and migraine. Well established coffee/caffeine usage has been connected with expectation of mental disintegration, and diminished risk of making stroke, Parkinson's ailment and Alzheimer's ailment. Its usage does not seem to influence seizure occasion. Thusly, everyday coffee and caffeine confirmation can be significant for a strong changed diet; its use does not ought to be ended in elderly people.
Up to 2% of the population is affected with alopecia areata (AA), a prevalent chronic tissue-specific autoimmune disease that causes hair loss. The specific pathobiology of AA is still unknown, however the most widely accepted idea is that an immunological process led the hair follicle's immune privilege to collapse. The etiology of AA is influenced by numerous environmental and genetic variables. One or more well-defined patches, more diffuse or total hair loss of the scalp (alopecia totalis), or hair loss of the entire body are all clinically treated for AA using a variety of clinical approaches (alopecia universalis). Corticosteroids and other immunomodulators, minoxidil, and contact immunotherapy are some of the available treatments for AA.
The most prevalent metabolic illness, diabetic mellitus (DM), is caused by a problem with insulin production. DM promotes the gradual degeneration of pancreatic cells, which raises blood sugar levels. Around 2.1 trillion dollars are invested in global health industries by diabetic wound repair therapies. This is a result of the difficulties that skin ulcers offer in the wound healing process, such as a shortage of macrophage and fibroblast growth factors (TGF-b1 and PDGF, respectively), all of which are required for the production of extracellular matrix (ECM). Nanofibers have been created by electrospinning with large porosity, excellent humidity absorption, a superior oxygen exchange rate, and certain antibacterial properties in response to the growth of medicinal materials and pharmaceutical technology. By including bioactive substances (such growth factors, genes, proteins/peptides, stem cells/exosomes, etc.) and nonbioactive materials, these nanoparticles/hydrogels aid in the healing of diabetic wounds (metal ions, oxygen, nitric oxide, etc.) Due to the slow wound healing process, wound care is a significant biomedical topic that presents difficulties. Malnutrition, insufficient oxygen, smoking, illnesses (such as diabetes and cancer), microbial infections, and other conditions are some of the causes of sluggish wound healing. Currently utilized wound dressings have a number of drawbacks, such as inadequate antibacterial action. Thus, we aimed to go into further depth about the NF (nanofiber) system's aforementioned characteristics for DM complications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.